Dyne Therapeutics, Inc.

DYN·NasdaqGS·Healthcare
Compare
18.54+0.49 (+2.71%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market18.29−0.25 (−1.35%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close18.05
Open18.57
Day range17.9419.00
52-week range14.0027.31
Off day high−2.42%
Off 52-week high−32.10%
Volume3.65M
Avg. volume (3M)2.78M
Market cap3.46B
EPS (TTM)-3.30
Forward P/E-5.60
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.21
Shares outstanding186.75M
Short interest17.44% of float
Earnings dateNov 5, 2026 (est.)
Analyst target34.33
Profit margin0.00%

Against its peers

Compare in full ›
DYN DSGN SRPT EWTX SLDB DNTH
Market cap 3.46B 665.24M 2.01B 4.08B 699.11M 4.80B
P/E (TTM) — — — — — —
Forward P/E -5.6 -6.6 7.8 -20.1 -3.8 -18.6
Price/book 4.4 3.0 1.3 7.6 2.9 7.5
Dividend yield — — — — — —
1-year change −13.64% +54.73% +7.65% +119.60% +54.69% +135.55%
Today +2.71% +2.80% +2.43% −0.40% +3.82% +3.76%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Dyne Therapeutics's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Design Therapeutics, Inc.DSGN · Biotechnology 665.24M 10.63 +2.80%
Sarepta Therapeutics, Inc.SRPT · Biotechnology 2.01B 18.99 +2.43%
Edgewise Therapeutics, Inc.EWTX · Biotechnology 4.08B 37.53 −0.40%
Solid Biosciences Inc.SLDB · Biotechnology 699.11M 6.52 +3.82%
Dianthus Therapeutics, Inc.DNTH · Biotechnology 4.80B 85.81 +3.76%
PTC Therapeutics, Inc.PTCT · Biotechnology 5.76B 68.97 +1.25%
Neuren Pharmaceuticals LimitedNEU.AX · Biotechnology 2.95B 23.24 +17.49%
PYC Therapeutics LimitedPYC.AX · Biotechnology 1.90B 1.9300 +4.32%

Also based in Waltham, Massachusetts, then elsewhere in Massachusetts.

Company Mkt cap Price Today
Thermo Fisher Scientific Inc.TMO · Waltham, MA 261.64B 706.16 +1.12%
Veralto CorporationVLTO · Waltham, MA 28.45B 117.02 +0.60%
Revvity, Inc.RVTY · Waltham, MA 17.79B 159.43 −2.48%
Repligen CorporationRGEN · Waltham, MA 11.39B 178.20 −0.04%
Spyre Therapeutics, Inc.SYRE · Waltham, MA 9.26B 99.04 −0.23%
Pegasystems Inc.PEGA · Waltham, MA 5.62B 34.36 +0.03%
Cogent Biosciences, Inc.COGT · Waltham, MA 5.46B 31.49 +1.38%
Crane NXT, Co.CXT · Waltham, MA 3.55B 61.62 +2.63%

The stocks whose daily moves over the past year went most closely with Dyne Therapeutics's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Solid Biosciences Inc.SLDB · Correlation 0.49 699.11M 6.52 +3.82%
Sarepta Therapeutics, Inc.SRPT · Correlation 0.48 2.01B 18.99 +2.43%
Denali Therapeutics Inc.DNLI · Correlation 0.48 3.35B 20.96 +7.76%
PTC Therapeutics, Inc.PTCT · Correlation 0.46 5.76B 68.97 +1.25%
Dianthus Therapeutics, Inc.DNTH · Correlation 0.43 4.80B 85.81 +3.76%
IDEAYA Biosciences, Inc.IDYA · Correlation 0.43 3.12B 32.36 +3.29%
Kailera Therapeutics, Inc.KLRA · Correlation 0.36 1.66B 12.80 +1.75%
Spyre Therapeutics, Inc.SYRE · Correlation 0.36 9.26B 99.04 −0.23%

What visitors to Dyne Therapeutics's page also look at.

Company Mkt cap Price Today
Empire Petroleum CorporationEP 85.70M 2.0600 0.00%
The AES CorporationAESOdds 10.63B 14.90 −0.13%
Mirion Technologies, Inc.MIR 4.48B 17.97 −5.67%
CMS Energy CorporationCMS 22.26B 70.98 +1.40%
Williams Companies, Inc. (The)WMB 84.84B 67.86 −6.36%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All DYN news ›
markets.businessinsider.com·Positive

Dyne Therapeutics management to meet with Piper Sandler

Meeting to be held on October 5-8 hosted by Piper Sandler. Published first on TheFly – the ultimate source for real-time, market-moving breakin... Dyne Therapeutics management to meet with Piper Sandler Meeting to be held on October 5-8…

PFERCKT
markets.businessinsider.com··2 outletsPositive

Dyne Therapeutics Announces Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1)

- Data from a pooled dose group of participants initially enrolled in the multiple ascending dose (MAD) portion of ACHIEVE showed functional improvement versus baseline, versus placebo and versus a matched natural history cohort across…

NVSDYN
More from 1 other outlet

From the 4Search news index, newest first.

In the news

12mentions in 30 days
11with it in the headline
Negativesentiment

Mentioned with

Morgan Stanley5Morgan Stanley & CO Llc5The Company5Dnb Carnegie4Jefferies Llc4Wedbush4Biotechnology & Medical Research Rbc3Brokerages3

People in the coverage

Mitch Edgeman8Benzinga7HC Wainwright7Danessa Lincoln6Sarita Garza6Piper Sandler5

Themes

Equities9Healthcare8Finanzen6Biotechnology5Analysis4Consensus4Ratings4Dnb Carnegie3

Most coverage from

  1. marketscreener.com7
  2. markets.businessinsider.com3
  3. seekingalpha.com1
  4. themarketsdaily.com1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 12 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance